1. Home
  2. PCRX vs UAMY Comparison

PCRX vs UAMY Comparison

Compare PCRX & UAMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pacira BioSciences Inc.

PCRX

Pacira BioSciences Inc.

HOLD

Current Price

$25.96

Market Cap

999.0M

Sector

Health Care

ML Signal

HOLD

Logo United States Antimony Corporation

UAMY

United States Antimony Corporation

HOLD

Current Price

$5.15

Market Cap

955.8M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
PCRX
UAMY
Founded
2006
1968
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Metal Fabrications
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
999.0M
955.8M
IPO Year
2010
1997

Fundamental Metrics

Financial Performance
Metric
PCRX
UAMY
Price
$25.96
$5.15
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
5
Target Price
$30.25
$9.44
AVG Volume (30 Days)
479.1K
5.9M
Earning Date
04-30-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
107.44
N/A
EPS
0.07
N/A
Revenue
$541,533,000.00
$39,257,708.00
Revenue This Year
$6.78
$219.89
Revenue Next Year
$8.54
$104.28
P/E Ratio
$370.43
N/A
Revenue Growth
26.04
162.80
52 Week Low
$18.80
$2.80
52 Week High
$27.64
$19.71

Technical Indicators

Market Signals
Indicator
PCRX
UAMY
Relative Strength Index (RSI) 60.51 34.32
Support Level $21.89 $5.12
Resistance Level $26.94 $8.28
Average True Range (ATR) 0.82 0.44
MACD -0.03 -0.03
Stochastic Oscillator 56.59 6.05

Price Performance

Historical Comparison
PCRX
UAMY

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

About UAMY United States Antimony Corporation

United States Antimony Corp is a fully integrated mining, transportation, milling, smelting, and selling company. It has two operating segments: antimony and zeolite. Its products and services include antimony; silver; gold; zeolite products; and storage, handling, & packaging services. The company's geographical segments are the Domestic, Canada, and Mexico, of which the vast majority of its revenue comes from the Domestic.

Share on Social Networks: